Skip to content
healthcare.dev
Get a free key

ELAPRASE

NDC 54092-700, idursulfase, solution, concentrate, from Takeda Pharmaceuticals America, Inc..

Product NDC
54092-700
Status
Listed
Labeler
Takeda Pharmaceuticals America, Inc.
Dosage form
SOLUTION, CONCENTRATE
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
BLA
Application
BLA125151
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/54092-700 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • IDURSULFASE6 mg/3mL

Pharmacologic classes

Hydrolytic Lysosomal Glycosaminoglycan-specific Enzyme [EPC]; alpha-Glucosidases [CS]

Package NDCNDC-11Package
54092-700-01540920700011 VIAL, GLASS in 1 BOX (54092-700-01) / 3 mL in 1 VIAL, GLASS

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/60cba843-5aab-4dd7-96dc-66648d413be3

  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=54092-700

Use it

Look up 54092-700 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/54092-700 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 54092-700. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.